Literature DB >> 27281206

Immunotherapy: Cancer vaccine triggers antiviral-type defences.

Jolanda De Vries1, Carl Figdor1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27281206     DOI： 10.1038/nature18443

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  T cell exclusion, immune privilege, and the tumor microenvironment.

Authors:  Johanna A Joyce; Douglas T Fearon
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

Review 2.  Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.

Authors:  Paul J Tacken; I Jolanda M de Vries; Ruurd Torensma; Carl G Figdor
Journal:  Nat Rev Immunol       Date:  2007-10       Impact factor: 53.106

3.  Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro.

Authors:  Luis J Cruz; Paul J Tacken; Remco Fokkink; Ben Joosten; Martien Cohen Stuart; Fernando Albericio; Ruurd Torensma; Carl G Figdor
Journal:  J Control Release       Date:  2010-02-13       Impact factor: 9.776

Review 4.  Cancer immunotherapy via dendritic cells.

Authors:  Karolina Palucka; Jacques Banchereau
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

5.  Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.

Authors:  Paul J Tacken; I Jolanda M de Vries; Karlijn Gijzen; Ben Joosten; Dayang Wu; Russell P Rother; Susan J Faas; Cornelis J A Punt; Ruurd Torensma; Gosse J Adema; Carl G Figdor
Journal:  Blood       Date:  2005-05-05       Impact factor: 22.113

6.  Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo.

Authors:  A N Kuhn; M Diken; S Kreiter; A Selmi; J Kowalska; J Jemielity; E Darzynkiewicz; C Huber; O Türeci; U Sahin
Journal:  Gene Ther       Date:  2010-04-22       Impact factor: 5.250

7.  Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients.

Authors:  Jurjen Tel; Erik H J G Aarntzen; Tetsuro Baba; Gerty Schreibelt; Barbara M Schulte; Daniel Benitez-Ribas; Otto C Boerman; Sandra Croockewit; Wim J G Oyen; Michelle van Rossum; Gregor Winkels; Pierre G Coulie; Cornelis J A Punt; Carl G Figdor; I Jolanda M de Vries
Journal:  Cancer Res       Date:  2013-01-23       Impact factor: 12.701

8.  Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.

Authors:  Lena M Kranz; Mustafa Diken; Heinrich Haas; Sebastian Kreiter; Carmen Loquai; Kerstin C Reuter; Martin Meng; Daniel Fritz; Fulvia Vascotto; Hossam Hefesha; Christian Grunwitz; Mathias Vormehr; Yves Hüsemann; Abderraouf Selmi; Andreas N Kuhn; Janina Buck; Evelyna Derhovanessian; Richard Rae; Sebastian Attig; Jan Diekmann; Robert A Jabulowsky; Sandra Heesch; Jessica Hassel; Peter Langguth; Stephan Grabbe; Christoph Huber; Özlem Türeci; Ugur Sahin
Journal:  Nature       Date:  2016-06-01       Impact factor: 49.962

9.  Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.

Authors:  Laura Bonifaz; David Bonnyay; Karsten Mahnke; Miguel Rivera; Michel C Nussenzweig; Ralph M Steinman
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

10.  In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.

Authors:  Laura C Bonifaz; David P Bonnyay; Anna Charalambous; Dara I Darguste; Shin-Ichiro Fujii; Helena Soares; Marie K Brimnes; Bruno Moltedo; Thomas M Moran; Ralph M Steinman
Journal:  J Exp Med       Date:  2004-03-15       Impact factor: 14.307
  10 in total
  13 in total

1.  Towards superior dendritic-cell vaccines for cancer therapy.

Authors:  Mansi Saxena; Sreekumar Balan; Vladimir Roudko; Nina Bhardwaj
Journal:  Nat Biomed Eng       Date:  2018-06-11       Impact factor: 25.671

2.  Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma.

Authors:  Motao Zhu; Xilai Ding; Ruifang Zhao; Xuewu Liu; Haifa Shen; Chunmei Cai; Mauro Ferrari; Helen Y Wang; Rong-Fu Wang
Journal:  J Control Release       Date:  2018-01-08       Impact factor: 9.776

3.  The Antibody Repertoire of Colorectal Cancer.

Authors:  Seong Won Cha; Stefano Bonissone; Seungjin Na; Pavel A Pevzner; Vineet Bafna
Journal:  Mol Cell Proteomics       Date:  2017-10-18       Impact factor: 5.911

Review 4.  Engineering and physical sciences in oncology: challenges and opportunities.

Authors:  Michael J Mitchell; Rakesh K Jain; Robert Langer
Journal:  Nat Rev Cancer       Date:  2017-10-13       Impact factor: 60.716

5.  Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors.

Authors:  Alexandra-Chloé Villani; Rahul Satija; Gary Reynolds; Siranush Sarkizova; Karthik Shekhar; James Fletcher; Morgane Griesbeck; Andrew Butler; Shiwei Zheng; Suzan Lazo; Laura Jardine; David Dixon; Emily Stephenson; Emil Nilsson; Ida Grundberg; David McDonald; Andrew Filby; Weibo Li; Philip L De Jager; Orit Rozenblatt-Rosen; Andrew A Lane; Muzlifah Haniffa; Aviv Regev; Nir Hacohen
Journal:  Science       Date:  2017-04-21       Impact factor: 47.728

6.  A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant response.

Authors:  Emiliano Manzo; Adele Cutignano; Dario Pagano; Carmela Gallo; Giusi Barra; Genoveffa Nuzzo; Clementina Sansone; Adrianna Ianora; Konrad Urbanek; Daniela Fenoglio; Francesca Ferrera; Cinzia Bernardi; Alessia Parodi; Giuseppe Pasquale; Antonio Leonardi; Gilberto Filaci; Raffaele De Palma; Angelo Fontana
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

Review 7.  Immune Checkpoint in Glioblastoma: Promising and Challenging.

Authors:  Jing Huang; Fangkun Liu; Zhixiong Liu; Hui Tang; Haishan Wu; Qianni Gong; Jindong Chen
Journal:  Front Pharmacol       Date:  2017-05-09       Impact factor: 5.810

Review 8.  Manipulation of Innate and Adaptive Immunity through Cancer Vaccines.

Authors:  Elias J Sayour; Duane A Mitchell
Journal:  J Immunol Res       Date:  2017-02-06       Impact factor: 4.818

9.  Cancer immunoediting: A game theoretical approach.

Authors:  Fatemeh Tavakoli; Javad Salimi Sartakhti; Mohammad Hossein Manshaei; David Basanta
Journal:  In Silico Biol       Date:  2021

Review 10.  Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes.

Authors:  Elias J Sayour; Hector R Mendez-Gomez; Duane A Mitchell
Journal:  Int J Mol Sci       Date:  2018-09-23       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.